Veozah

Dec 19 2024

(READ) FDA adds Boxed Warning to hot flash drug

By Sharyl Attkisson / December 19, 2024

The following is from MedPage Today. The FDA has added a boxed warning to fezolinetant (Veozah), a hormone-free treatment for menopause-related hot flashes, citing the risk of rare but severe liver injury. The warning follows an initial drug safety communication […]

(READ) FDA adds Boxed Warning to hot flash drug Read More »

Sep 20 2024

(READ) FDA warning added hot flash drug Veozah

By Sharyl Attkisson / September 20, 2024

The following is an excerpt from MedPage Today. The US Food and Drug Administration (FDA) has issued a warning regarding the use of Veozah (fezolinetant), a hormone-free drug used to treat moderate to severe hot flashes (vasomotor symptoms) in menopausal women. The FDA

(READ) FDA warning added hot flash drug Veozah Read More »

(READ) FDA adds Boxed Warning to hot flash drug

(READ) FDA warning added hot flash drug Veozah

Keep Independent Journalism Alive

Subscribe To The Newspresso Daily